ASMB Assembly Biosciences, Inc.

+0  (1%)
Previous Close 23.81
Open 23.87
Price To book 5.14
Market Cap 414.01M
Shares 17,265,000
Volume 64,126
Short Ratio 4.55
Av. Daily Volume 55,561

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data from second trial did not meet primary endpoint - Feb 2014. Will not pursue future development
VEN 307 (diltiazem cream)
Anal fissures